HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MR imaging of Hippel-Lindau disease: value of gadopentetate dimeglumine.

Abstract
Hippel-Lindau disease is an autosomal dominant disorder characterized by tumors of the central nervous system and abdominal viscera. Frequent multisystem radiologic evaluation of persons at risk is desirable. Twenty-seven patients with Hippel-Lindau disease or a family history of the disease were examined with both unenhanced and gadopentetate dimeglumine-enhanced magnetic resonance (MR) imaging to study the usefulness of the contrast medium in the evaluation of these patients. The MR studies were correlated with computed tomographic (CT) scans in seven patients and cerebral angiograms in five. Twelve patients had hemangioblastomas in the brain, and eight of these patients also had spinal cord lesions (most were multiple), well demonstrated with gadopentetate dimeglumine. Contrast-enhanced MR imaging enabled detection of more central nervous system lesions and provided better delineation than unenhanced MR imaging, CT, or angiography. In addition, four patients with multiple renal cysts seen on CT scans and unenhanced MR images had enhancing lesions that were later proved to be renal cell carcinoma at angiography and/or surgery. Four patients had cystic lesions in the pancreas that did not enhance and were later proved to be pancreatic cysts. The authors conclude that gadopentetate dimeglumine-enhanced MR imaging appears to be a useful method for evaluating and following up patients with Hippel-Lindau disease.
AuthorsD R Nelson, W T Yuh, M H Waziri, T J Ryals, Y Sato, S C Kao, D R Hawes, R D Williams
JournalJournal of magnetic resonance imaging : JMRI (J Magn Reson Imaging) 1991 Jul-Aug Vol. 1 Issue 4 Pg. 469-76 ISSN: 1053-1807 [Print] United States
PMID1790370 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • Drug Combinations
  • Organometallic Compounds
  • Meglumine
  • Pentetic Acid
  • Gadolinium DTPA
Topics
  • Adolescent
  • Adult
  • Contrast Media
  • Drug Combinations
  • Female
  • Gadolinium DTPA
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Meglumine
  • Middle Aged
  • Organometallic Compounds
  • Pentetic Acid
  • Prospective Studies
  • von Hippel-Lindau Disease (diagnosis, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: